Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured eBook
The “Best Practice Organization” and Its Importance for Success in Today’s Biopharma Industry
Learn More >
Whitepaper
Building Peak Performance Go-to-Market Operations: Capturing the Value of Medical Innovation in a Fast-Changing Landscape
Blog
7 “Make or Break” Factors for Emerging Biopharma Companies: Factor 6 – “Right-Sizing” the Launch
Blog
7 “Make or Break” Factors for Emerging Biopharma Companies: Factor 5 – Choosing the Best Commercial Path Forward
Blog
7 “Make or Break” Factors for Emerging Biopharma Companies: Factor 4 – Knowing What It Will Take to Commercialize
Blog
7 “Make or Break” Factors for Emerging Biopharma Companies: Factor 3 – Integrating the Commercial Perspective into Clinical & Corporate Decisions
Whitepaper
Commercializing Gene Therapies, Part 4 – Market Entry
Blog
Commercializing Gene Therapies: Navigating Complexity to Build Commercial Models That Work, Part IV – Commercial Planning & Market Entry
Whitepaper
Commercializing Gene Therapies, Part 3 – Cost Drivers
Blog
Commercializing Gene Therapies: Navigating Complexity to Build Commercial Models That Work (Part III – Cost Drivers)
Whitepaper
Commercializing Gene Therapies, Part 2 – Supply Chain Considerations
Blog
Commercializing Gene Therapies: Navigating Complexity to Build Commercial Models that Work (Part II – Supply Chain Considerations)
Whitepaper
Commercializing Gene Therapies, Part 1 – Introduction
Blog
Commercializing Gene Therapies: Navigating Complexity to Build Commercial Models That Work (Part I – Introduction)
Blog
12 Pitfalls in Europe: Pitfall #12 – Caring too late about your infrastructure
Blog
12 Pitfalls in Europe: Pitfall #11 – Using Individual Preferences vs. Analysis to Select HQ Location
Blog
12 Pitfalls in Europe: Pitfall #10 – Building Like Big Pharma When You’re Not
